Microcap biotech developer Adeona Pharmaceuticals (AEN) continues to rally today, up another 19%...


Microcap biotech developer Adeona Pharmaceuticals (AEN) continues to rally today, up another 19% after reporting positive Phase I/II results on Wednesday for its clinical collaborator for Lou Gehrig's disease.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs